2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
about
Concomitant atrial fibrillation surgery for people undergoing cardiac surgeryAlmanac 2015: atrial fibrillation research in HeartAspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-AnalysisPerioperative atrial fibrillation: a systematic review of evolving therapeutic options in pharmacologic and procedural managementCatheter Ablation for Long-Standing Persistent Atrial FibrillationAntithrombotic management of atrial fibrillation in the elderlyPharmacotherapy in the cardiac catheterization laboratory: evolution and recent developmentsCryoballoon ablation of atrial fibrillation: a practical and effective approachDirect oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic reviewEvaluating the benefits of home-based management of atrial fibrillation: current perspectivesUse of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillationThromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysisSinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?Cardioembolic Stroke.Atrial fibrillation in women: treatmentConcomitant atrial fibrillation surgery for people undergoing cardiac surgery.Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac SurgeryWhole Exome Sequencing in Atrial Fibrillation.2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Quantitative tissue-tracking cardiac magnetic resonance (CMR) of left atrial deformation and the risk of stroke in patients with atrial fibrillation.Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationOral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.Symptom Clusters in Adults With Chronic Atrial Fibrillation.Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery.Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).Flecainide and elevated liver enzymes in α1-antitrypsin deficiencyRadiation-associated plasmacytoma following catheter ablation for atrial fibrillation.Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 PatientsAtrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysisAntithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for StrokeAddressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation.Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study.The AFFORD clinical decision aid to identify emergency department patients with atrial fibrillation at low risk for 30-day adverse events.[Interventional treatment for paroxysmal atrial fibrillation : which is the optimal ablation approach?].A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control studyControversies in cardioembolic stroke.Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart StudyClinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation
P2860
Q24188130-5DE08AE0-860B-4D2B-BF7B-D00788B2475FQ26770598-2E19D889-6C4C-43C6-95E5-143A2553BC64Q26777365-C5E58A55-2DC3-4469-B80E-A0AB9430E9F6Q26781769-7B7CAF92-703C-4964-B58E-56A596A44ED9Q26797441-0EF695BB-6210-4395-96B4-9B1688F2F205Q26827113-DF7FCD38-A407-4151-B8DE-907BA4E0707DQ26862694-9BA5CC86-2909-473F-9D74-5FD307EC3548Q28067645-C7507887-ECD8-4DDC-91F8-A83F352433FFQ28071807-CEE25BF5-924B-4C56-AA96-2BAC16605E93Q28079137-F75BACB7-A68F-4CE4-8EF5-DB3B6798B047Q28607864-4A2D4A9D-A9AB-49D4-A7F4-13B17C483BF9Q29994528-99356938-F10E-4423-A577-A447505AB137Q30238620-56011ED4-DBE0-4D87-AB95-710435D9B434Q30238631-F4A2C83C-6C21-4D80-BDC8-CAF98E119DBCQ30241862-AA25B594-BB7C-4035-8958-BBBCDA113455Q30248343-5A748F56-6E26-40B4-A70A-E92424EB5BEFQ30277039-6141C3A4-7839-4124-98DF-020B90B16285Q30489794-B295A55D-F691-4A0A-A9A7-C60D3308ADB0Q30653045-44ECBAF4-5E5D-427B-A232-BE417BBB559CQ30665286-05A50085-FFA5-4F8B-B678-FA326148A165Q31157420-7979AE8E-F270-4022-8398-0F4F61472277Q31170904-C2D0B36F-0683-4AE3-B973-0575318BAD0EQ33167198-EF97FC5A-3B69-41DA-9813-D2C004A8B676Q33583698-E483AF0B-98EE-4005-894D-9076A3D728ADQ33601396-067681EC-3C18-40BC-AF63-9D9DA8C7B0DBQ33643591-292A33D4-F1BA-4C58-B5AD-3BC5F49DBFDEQ33644468-0AB3C509-E45F-4B63-9C3F-78F54845A6E1Q33792405-34EBEAA5-9309-4F08-B90B-DFF0F09A7207Q33794241-F4FE007E-14B4-45DC-9331-D6A0DDED6A51Q34670524-A44796FB-F6DC-4246-9A33-9DDD87001685Q34725585-DB4353FC-D9D9-4B86-886E-08FDF70DD55BQ34765387-F627A41B-8A5D-478F-A23B-D38DA270674AQ35044476-6A2E7DA1-AE3D-45CA-AA31-1A5C506A6E56Q35070863-5065C826-FF07-42DE-B0C2-C00FEFCD71A7Q35137611-BEABF194-897E-445E-8144-D436D9E6965FQ35542264-6E9C67F2-EB7A-4989-A871-3A48A2A80C4DQ35568298-BAEEBC75-1AF9-4F7B-B384-BF50DDD1F661Q35570827-D766C0CB-A044-4E3E-9E23-01AE2DCAB04CQ35602612-2DAAF2F7-09F0-4205-AA3C-BBAE248CFC08Q35638248-F0498862-233C-4C37-A2D6-6FF2B3508D1F
P2860
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
2014 AHA/ACC/HRS Guideline for ...... s and the Heart Rhythm Society
@nl
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@ast
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@en
type
label
2014 AHA/ACC/HRS Guideline for ...... s and the Heart Rhythm Society
@nl
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@ast
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@en
prefLabel
2014 AHA/ACC/HRS Guideline for ...... s and the Heart Rhythm Society
@nl
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@ast
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@en
P2093
P2860
P50
P3181
P1433
P1476
2014 AHA/ACC/HRS guideline for ...... and the Heart Rhythm Society.
@en
P2093
ACC/AHA Task Force Members
Craig T January
Cynthia M Tracy
Jamie B Conti
Joaquin E Cigarroa
Joseph C Cleveland
Joseph S Alpert
Katherine T Murray
L Samuel Wann
Michael D Ezekowitz
P2860
P304
P3181
P356
10.1161/CIR.0000000000000041
P407
P577
2014-03-28T00:00:00Z